Esperion Therapeutics (ESPR) Return on Capital Employed Growth (5y) (2018 - 2026)
Esperion Therapeutics (ESPR) Return on Capital Employed Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Esperion Therapeutics | 799.30 Mn | 643.14 Mn | 45.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,577.00 |
| Dec 31, 2025 | 11,116.00 |
| Sep 30, 2025 | 88,362.00 |
| Jun 30, 2025 | -5,551.00 |
| Mar 31, 2025 | 14,243.00 |
| Dec 31, 2024 | 12,092.00 |
| Sep 30, 2024 | 5,205.00 |
| Jun 30, 2024 | 3,909.00 |
| Mar 31, 2024 | 2,669.00 |
| Dec 31, 2023 | -5,466.00 |
| Sep 30, 2023 | -5,090.00 |
| Jun 30, 2023 | -3,247.00 |
| Mar 31, 2023 | -4,414.00 |
| Dec 31, 2022 | -3,102.00 |
| Sep 30, 2022 | -1,070.00 |
| Jun 30, 2022 | -786.00 |
| Mar 31, 2022 | -1,694.00 |
| Dec 31, 2021 | -6,667.00 |
| Sep 30, 2021 | -13,003.00 |
| Jun 30, 2021 | -12,786.00 |